The Southern University of Science and Technology in the southern
Chinese city of Shenzhen said it had been unaware of the research
project and that the academic, He Jiankui, had been on leave without
pay since February.
The work is a "serious violation of academic ethics and standards",
it said.
The university issued a statement after he said in five videos
posted on the video-sharing website on Monday that he used a
gene-editing technology known as CRISPR-Cas9 to edit the genes of
twin girls.
The editing process, which he calls gene surgery, "worked safely as
intended" and the girls are "as healthy as any other babies", he
says in one video. It was impossible to verify the claims as He did
not provide any written documentation of his research.
CRISPR-Cas9 is a technology that allows scientists to essentially
cut-and-paste DNA, raising hope of genetic fixes for disease.
However, there are also concerns about its safety and ethics.
"If true, this experiment is monstrous," said Julian Savulescu,
director of the Oxford Uehiro Centre for Practical Ethics at the
University of Oxford.
Southern University of Science and Technology said it would form an
independent committee of experts to investigate. It said He is on
unpaid leave until 2021.
"Southern University of Science and Technology strictly requires
scientific research to conform to national laws and regulations and
to respect and comply with international academic ethics and
standards,” it said.
Reached for comment on the university's statement, He said he had
been on voluntary leave for several years to focus on his research,
without specifying dates.
In the videos, the scientist defended his work, saying in one: "I
understand my work will be controversial, but I believe families
need this technology. And I’m willing to take the criticism for
them."
[to top of second column] |
In an earlier email to Reuters, He said that he planned to share
data about the trial at a scientific forum this week. He said he
planned for it to also go "through the peer review process, and
through a pre-print soon." A pre-print is a publication of findings
made before the research is published in a peer-reviewed journal.
The MIT Technology Review and the Associated Press first reported on
He's latest work.
In an earlier telephone interview and emails with Reuters, He said
he was aiming to bestow on the gene edited babies "lifetime
protection" against HIV, the virus that causes AIDS.
He said he began his work in the second half of 2017 and enrolled
eight couples. All of the potential fathers involved were
HIV-positive. Five chose to implant embryos, including the parents
of the twin girls, identified only by the pseudonyms Mark and Grace.
The babies' names are Lulu and Nana, He said in one video.
In April 2015, scientists at Sun Yat-sen University sparked a global
controversy after they published results of an experiment that used
CRISPR-Cas9 to edit the genes of non-viable human embryos.
Describing He's work, University of Oxford's Savulescu said: "These
healthy babies are being used as genetic guinea pigs. This is
genetic Russian Roulette."
(Reporting by Alexandra Harney in Shanghai and Kate Kelland in
London; Additional reporting by Philip Wen in Beijing; Editing by
Neil Fullick)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|